Genotoxicity of adriamycin in human cell lines differing in antioxidant enzymes activity

Acta Poloniae Pharmaceutica - Drug Research

Volumn 56, Issue 1, 1999, Pages 35-39

  Chłopkiewicz, Bozena ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

Adriamycin; Chromosome aberrations; Genotoxicity; Human cells; Micronucleus assay

Indexed keywords

ANTIOXIDANT; CAFFEINE; CELL DNA; DOXORUBICIN; EPIRUBICIN;

ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA REPAIR; EMBRYO; ENZYME ACTIVITY; GENOTOXICITY; HUMAN; HUMAN CELL; MICRONUCLEUS TEST;

ANTINEOPLASTIC AGENTS; CAFFEINE; CATALASE; CELL LINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMOSOME ABERRATIONS; DOXORUBICIN; HUMANS; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MUTAGENICITY TESTS; SUPEROXIDE DISMUTASE;

EID: 0344507204     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Vig B.K.: Cancer Res. 31, 32-38 (1971).
2. Vig B.K.: Mutation Res. 39, 189-238 (1977).
3. Vig B.K.: Cancer Chemother. Pharmacol. 3, 143-160 (1979).
4. Al.-Shabanah O.A.: Mutation Res. 301, 107-111 (1983).
5. Chłopkiewicz B., Gruber B.: Acta Polon. Pharm. - Drug Res. 54, 437-441 (1997).
6. Gruber B.M., Anuszewska E.L.: Acta Biochim. Pol. 45, 573-577 (1998).
7. Potmesil M., Kirschenbaum S., Israel M., Levin M., Khetapol V.K., Silber R.: Cancer Res. 43, 3528-3533 (1983).
8. Capranico G., Babuduri N., Casciarri G., Dozani L., Gambetta R.A., Longoni E., Pani B., Soranzo C., Zunino F.: Chem. Biol. Interact. 57, 189-201 (1986).
9. Heddle J.A., Hite M., Kirkhart B., Mavourin K., MacGregor J.T., Neewell G.W., Salamone M.F.: Mutation Res. 123, 61-118 (1983).
10. Matsuoka A., Yamazaki N., Suzuki T., Haayashi M., Sofuni T.: Mutation Res. 272, 223-236 (1993).
11. Ross W.E., Zwelling L.A., Kohn K.W.: Int. J. Radiation Oncology Biol. Phys., 5, 1221-1224 (1979).
12. Dunn T.L., Gardiner R.A., Seymour G.J., Lavin H.F.: Mutation Res. 189, 299-306 (1987).